Proposed Data Collections Submitted for Public Comment and Recommendations, 22267-22268 [2013-08730]

Download as PDF 22267 Federal Register / Vol. 78, No. 72 / Monday, April 15, 2013 / Notices EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Hours per response Total burden hours Physician Questionnaire .................................................................................. Practice Organization Questionnaire ............................................................... 1,750 667 1 1 20/60 10/60 583 111 Total .......................................................................................................... 2,417 na na 694 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Form name Total burden hours Average hourly wage rate* Total cost burden Physician Questionnaire .................................................................................. Practice Organization Questionnaire ............................................................... 1750 667 583 111 $95.79 a 70.98 b $55,846 7,879 Total .......................................................................................................... 2,417 694 na 63,725 * National Compensation Survey: Occupational wages in the United States May 2011, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’ a Based on the mean wages for Pediatricians, General (29–1065); Family and General Practitioners (29–1062); Internists, General (29–1063); Psychiatrists (29–1066); Anesthesiologists (29–1061); Surgeons (29–1067); Obstetricians and Gynecologists (29–1064); and Physicians & Surgeons, All Other (29–1069) b Based on the mean wages for 334 Medical and Health Services Managers (11–9111) and 333 physicians (as defined above). Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: March 12, 2013. Carolyn M. Clancy, Director. sroberts on DSK5SPTVN1PROD with NOTICES [FR Doc. 2013–08409 Filed 4–12–13; 8:45 am] BILLING CODE 4160–90–M VerDate Mar<15>2010 17:00 Apr 12, 2013 Jkt 229001 DEPARTMENT OF HEALTH AND HUMAN SERVICES be received within 60 days of this notice. Centers for Disease Control and Prevention Proposed Data Collections Submitted for Public Comment and Recommendations Proposed Project Aggregate Reports for Tuberculosis Program Evaluation (0920–0457—Exp. 9–30–2013)—Extension—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 or send comments to Ron Otten, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should Background and Brief Description CDC requests the extension of the Aggregate Reports for Tuberculosis Program Evaluation, previously approved under OMB No. 0920–0457 for 3-years. There are no revisions to the report forms, data definitions, or reporting instructions. To ensure the elimination of tuberculosis in the United States, CDC monitors indicators for key program activities, such as finding tuberculosis infections in recent contacts of cases and in other persons likely to be infected and providing therapy for latent tuberculosis infection. In 2000, CDC implemented two program evaluation reports for annual submission: Aggregate report of followup for contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection (OMB No. 0920–0457). The respondents for these reports are the 68 state and local tuberculosis control programs receiving federal cooperative agreement funding through the CDC Division of Tuberculosis Elimination (DTBE). These reports emphasize treatment outcomes, high-priority target populations vulnerable to tuberculosis, [60Day-13–0457] PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\15APN1.SGM 15APN1 22268 Federal Register / Vol. 78, No. 72 / Monday, April 15, 2013 / Notices and programmed electronic report entry, which transitioned to the National Tuberculosis Indicators Project (NTIP), a secure web-based system for program evaluation data, in 2010. No other federal agency collects this type of national tuberculosis data, and the Aggregate report of follow-up for preparation and utilization of these reports at the local and state levels of public health jurisdiction. CDC also provides respondents with technical support for the NTIP software (Electronic—100%, Use of Electronic Signatures—No). There is no cost to respondents. contacts of tuberculosis, and Aggregate report of screening and preventive therapy for tuberculosis infection are the only data source about latent tuberculosis infection for monitoring national progress toward tuberculosis elimination with these activities. CDC provides ongoing assistance in the ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden hours Type of respondent Form name Data clerks and Program Managers. Follow-up and Treatment of Contacts to Tuberculosis Cases Form. Follow-up and Treatment of Contacts to Tuberculosis Cases Form. Follow-up and Treatment of Contacts to Tuberculosis Cases Form. Targeted Testing and Treatment for Latent Tuberculosis Infection. Targeted Testing and Treatment for Latent Tuberculosis Infection. Targeted Testing and Treatment for Latent Tuberculosis Infection. 100 1 (electronic) ............................. 30/60 50 18 1 (manual) ................................ 30/60 9 18 1 (manual) ................................ 3 54 100 1 (electronic) ............................. 30/60 50 18 1 (manual) ................................ 30/60 9 18 1 (manual) ................................ 3 54 ................................................... ........................ ................................................... ........................ 226 Program Mangers ...................... Data clerks ................................ Data clerks and Program Managers. Program Mangers ...................... Data clerks ................................ Total ................................... Ron A. Otten, Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–08730 Filed 4–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on DSK5SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Initial Review The meeting announced below concerns Conducting Public Health Research in Kenya, FOA GH10–003; Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH), FOA GH11–002; Conducting Public Health Research in China, FOA GH12–005; Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region, FOA GH13–001; Detecting Etiologies of Emerging Infectious Diseases at the Regional Level—Western Ghat Region of Karnataka and Kerala, India, FOA VerDate Mar<15>2010 17:00 Apr 12, 2013 Jkt 229001 GH13–003; Strengthening Surveillance for Japanese Encephalitis in India, FOA GH13–004; and Research and Technical Assistance for Public Health Interventions in Haiti to Support Postearthquake Reconstruction, Cholera and HIV/AIDS, FOA GH13–006, initial review. Correction: The notice was published in the Federal Register on April 4, 2013, Volume 78, Number 65, Pages 20319– 20320. The meeting announced and matters to be discussed should read as follows: Conducting Public Health Research in Kenya, FOA GH10–003; Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH), FOA GH11–002; Conducting Public Health Research in China, FOA GH12– 005; Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region, FOA GH13–001; Detecting Etiologies of Emerging Infectious Diseases at the Regional Level—Western Ghat Region of Karnataka and Kerala, India, FOA GH13–003; Strengthening Surveillance for Japanese Encephalitis in India, FOA GH13–004; and Research and Technical Assistance for Public Health Interventions in Haiti to Support Post- PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 earthquake Reconstruction, Cholera and HIV/AIDS, FOA GH13–006. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in Kenya, FOA GH10–003; Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH), FOA GH11–002; Conducting Public Health Research in China, FOA GH12– 005; Strengthening Disease Prevention Research Capacity for Public Health Action in Guatemala and the Central American Region, FOA GH13–001; Detecting Etiologies of Emerging Infectious Diseases at the Regional Level—Western Ghat Region of Karnataka and Kerala, India, FOA GH13–003; Strengthening Surveillance for Japanese Encephalitis in India, FOA GH13–004; and Research and Technical Assistance for Public Health Interventions in Haiti to Support Postearthquake Reconstruction, Cholera and HIV/AIDS, FOA GH13–006, initial review.’’ Contact Person for More Information: Lata Kumar, Scientific Review Officer, CGH Science Office, Center for Global Health, CDC, 1600 Clifton Road, NE., E:\FR\FM\15APN1.SGM 15APN1

Agencies

[Federal Register Volume 78, Number 72 (Monday, April 15, 2013)]
[Notices]
[Pages 22267-22268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-08730]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-13-0457]

Proposed Data Collections Submitted for Public Comment and
Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.

Proposed Project

Aggregate Reports for Tuberculosis Program Evaluation (0920-0457--
Exp. 9-30-2013)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).

Background and Brief Description

CDC requests the extension of the Aggregate Reports for
Tuberculosis Program Evaluation, previously approved under OMB No.
0920-0457 for 3-years. There are no revisions to the report forms, data
definitions, or reporting instructions.
To ensure the elimination of tuberculosis in the United States, CDC
monitors indicators for key program activities, such as finding
tuberculosis infections in recent contacts of cases and in other
persons likely to be infected and providing therapy for latent
tuberculosis infection. In 2000, CDC implemented two program evaluation
reports for annual submission: Aggregate report of follow-up for
contacts of tuberculosis, and Aggregate report of screening and
preventive therapy for tuberculosis infection (OMB No. 0920-0457). The
respondents for these reports are the 68 state and local tuberculosis
control programs receiving federal cooperative agreement funding
through the CDC Division of Tuberculosis Elimination (DTBE). These
reports emphasize treatment outcomes, high-priority target populations
vulnerable to tuberculosis,

[[Page 22268]]

and programmed electronic report entry, which transitioned to the
National Tuberculosis Indicators Project (NTIP), a secure web-based
system for program evaluation data, in 2010. No other federal agency
collects this type of national tuberculosis data, and the Aggregate
report of follow-up for contacts of tuberculosis, and Aggregate report
of screening and preventive therapy for tuberculosis infection are the
only data source about latent tuberculosis infection for monitoring
national progress toward tuberculosis elimination with these
activities. CDC provides ongoing assistance in the preparation and
utilization of these reports at the local and state levels of public
health jurisdiction. CDC also provides respondents with technical
support for the NTIP software (Electronic--100%, Use of Electronic
Signatures--No).
There is no cost to respondents.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden Total
Type of respondent Form name Number of responses per per response burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Data clerks and Program Follow-up and 100 1 (electronic).... 30/60 50
Managers. Treatment of
Contacts to
Tuberculosis
Cases Form.
Program Mangers................ Follow-up and 18 1 (manual)........ 30/60 9
Treatment of
Contacts to
Tuberculosis
Cases Form.
Data clerks.................... Follow-up and 18 1 (manual)........ 3 54
Treatment of
Contacts to
Tuberculosis
Cases Form.
Data clerks and Program Targeted Testing 100 1 (electronic).... 30/60 50
Managers. and Treatment for
Latent
Tuberculosis
Infection.
Program Mangers................ Targeted Testing 18 1 (manual)........ 30/60 9
and Treatment for
Latent
Tuberculosis
Infection.
Data clerks.................... Targeted Testing 18 1 (manual)........ 3 54
and Treatment for
Latent
Tuberculosis
Infection.
--------------------------------------------------------------------------------
Total...................... .................. .............. .................. .............. 226
----------------------------------------------------------------------------------------------------------------

Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2013-08730 Filed 4-12-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.